Stocksigma LogoStocksigma Logo

Acutaas Chemicals Delivers Strong Q2 FY27 Results and Upgrades Annual Guidance

Acutaas Chemicals reported robust Q2 FY27 results, with revenue from operations surging 42.7% YoY to ₹4,369mn, led by pharmaceutical intermediates

Acutaas Chemicals Delivers Strong Q2 FY27 Results and Upgrades Annual Guidance

Acutaas Chemicals Ltd · Press Release · 27 Oct 2026, 6:29 pm

Acutaas Chemicals Delivers Strong Q2 FY27 Results and Upgrades Annual Guidance Acutaas Chemicals reported robust Q2 FY27 results, with revenue from operations surging 42.7% YoY to ₹4,369mn, led by pharmaceutical intermediates. EBITDA jumped 84.6% YoY to ₹1,760mn as EBITDA margin expanded 920 bps YoY to 40.3%, while PAT rose 71.4% YoY to ₹1,231mn with margins at 28.2%. The company inaugurated its South Korea facility ahead of schedule to produce high-purity semiconductor chemicals. Backed by strong order visibility, management revised FY27 revenue growth guidance upward from 25% to ~30% and raised EBITDA margin guidance to 38-40%.

Original exchange filing (PDF)

More announcements from Acutaas Chemicals Ltd

All Acutaas Chemicals Ltd announcements